Boehringer Ingelheim, University of Dundee collaboration for newer class of drug development – proteolysis-targeting chimeras (PROTACs)
Boehringer Ingelheim and the University of Dundee will join forces in an exciting collaboration with the aim to develop a novel class... Read More